Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
04/16/1997 | EP0768312A2 Bis-Staurosporine and K-252a derivatives |
04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
04/16/1997 | EP0768304A1 N-(Pyrimidinyl)-benzenesulfonamides as medicaments |
04/16/1997 | EP0768089A1 Health composition |
04/16/1997 | EP0768083A2 The use of sertraline to treat post myocardial infarction patients |
04/16/1997 | EP0767801A1 Endothelin antagonists ii |
04/16/1997 | EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
04/16/1997 | EP0767792A1 Vitronectin receptor antagonists |
04/16/1997 | EP0767787A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
04/16/1997 | EP0767782A1 Aryl and heteroaryl alkoxynaphthalene derivatives |
04/16/1997 | EP0767675A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage |
04/16/1997 | EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin |
04/16/1997 | EP0701551B1 3-(indol-3-yl) propenoic acid derivatives useful as nmda antagonists |
04/16/1997 | EP0656780B1 Drugs containing diphosphonic acids and salts thereof |
04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
04/16/1997 | CN1147765A Remedy for pulmonary heart |
04/16/1997 | CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives |
04/16/1997 | CN1147512A Substituted 4H-pyrans |
04/16/1997 | CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant |
04/16/1997 | CN1147406A Cockscomb beverage |
04/16/1997 | CN1147401A Medicine for heart disease |
04/16/1997 | CN1034575C Producing process for selective adenosine receptor agents |
04/16/1997 | CN1034569C Endothelin receptor antagonists |
04/15/1997 | US5621113 4-[(thien-2-yl)methyl]-imidazole analgesics |
04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
04/15/1997 | US5620998 Cardiovascular disorders; hypotensive agents |
04/15/1997 | US5620997 Viricides, antiinflammatory agents, antiatherosclerotic agent |
04/15/1997 | US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals |
04/15/1997 | US5620992 Having 5-hydroxytryptamine receptor antagonist activity |
04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
04/15/1997 | US5620988 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
04/15/1997 | US5620979 Treating neuronal loss associated with stroke, ischemia, central nervous system trauma, hypoglycemia or surgery |
04/15/1997 | US5620978 Nervous system disorders |
04/15/1997 | US5620976 Benzoxazine derivatives |
04/15/1997 | US5620975 Pharmaceutical composition and method for the control of hypertension |
04/15/1997 | US5620966 11,21-bisphenyl-19-norpregnane derivatives |
04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
04/10/1997 | WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE |
04/10/1997 | WO1997012963A2 A paf-acetylhydrolase and use in therapy |
04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
04/10/1997 | WO1997012878A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists |
04/10/1997 | WO1997012874A1 Imidazole derivatives having affinity for alpha2 receptors activity |
04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
04/10/1997 | WO1997012627A1 Therapeutic administration of hemoglobin in cardiac arrest |
04/10/1997 | WO1997012625A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
04/10/1997 | WO1997012611A1 Treatment of atherosclerosis |
04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
04/10/1997 | DE19537548A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
04/10/1997 | DE19536891A1 Neue Aminosäurederivate, ihre Herstellung und Verwendung New amino acid derivatives, their preparation and use |
04/10/1997 | CA2233917A1 Therapeutic administration of hemoglobin in cardiac arrest |
04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
04/10/1997 | CA2233300A1 A paf-acetylhydrolase and use in therapy |
04/10/1997 | CA2231500A1 Novel amino acid derivatives, their preparation and use |
04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
04/10/1997 | CA2228938A1 Treatment of atherosclerosis |
04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
04/09/1997 | EP0767170A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof |
04/09/1997 | EP0766735A1 Class bi and ci scavenger receptors |
04/09/1997 | EP0766687A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity |
04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
04/09/1997 | EP0766667A1 Substituted azetidinone compounds useful as hypocholesterolemic agents |
04/09/1997 | EP0766570A1 Methods for treating respiratory disease |
04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
04/09/1997 | EP0588875B1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same |
04/09/1997 | CN1147251A Tetrasubstd. imidazole derivs., method for preparing same, resulting intermediates, use thereof as drug, and pharmaceutical composition contg. same |
04/09/1997 | CN1147250A Naphthalene derivs. as prostaglandin I2 agonists |
04/09/1997 | CN1146992A Process for preparation of intermediate (R)-3-amino-5-methoxychroman |
04/09/1997 | CN1034503C Pyrazolopyrimidinone antianginal agent preparing process |
04/09/1997 | CN1034498C Octahydronaphthalene oxime derivs. for cholesterol biosynthesis inhibition, their preparation and use |
04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
04/08/1997 | US5618938 Process for preparing stereo isomers of neurokinin receptor antagonists |
04/08/1997 | US5618843 Inhibit platelet aggregation |
04/08/1997 | US5618837 PDGF antagonists III |
04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
04/08/1997 | US5618794 α-glycosyl derivative of catecholamine or its salt, and its preparation and uses |
04/08/1997 | US5618792 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
04/08/1997 | US5618537 Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ |
04/08/1997 | US5618530 Quartenary polyallylamine |
04/08/1997 | CA2091204C Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
04/03/1997 | WO1997012055A1 Product and process to regulate actin polymerization |
04/03/1997 | WO1997012050A1 Method for transferring genes to the heart using aav vectors |
04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
04/03/1997 | WO1997011698A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
04/03/1997 | WO1997011693A1 Guanidino protease inhibitors |
04/03/1997 | WO1997011684A1 Use of heparinases to decrease inflammatory responses |
04/03/1997 | CA2233344A1 Guanidino protease inhibitors |
04/03/1997 | CA2233343A1 Use of heparinases to decrease inflammatory responses |